###begin article-title 0
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(FTO) </italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 69 74 <span type="species:ncbi:9606">women</span>
###xml 78 83 <span type="species:ncbi:9606">child</span>
###xml 476 484 <span type="species:ncbi:9606">patients</span>
The polycystic ovary syndrome (PCOS), a common endocrine disorder in women of child-bearing age, mainly characterised by chronic anovulation and hyperandrogenism, is often associated with insulin resistance (IR) and obesity. Its etiology and the role of IR and obesity in PCOS are not fully understood. We examined the influence of validated genetic variants conferring susceptibility to obesity and/or type 2 diabetes mellitus (T2DM) on metabolic and PCOS-specific traits in patients with PCOS.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(FTO</italic>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2</italic>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 520 569 520 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kooperative Gesundheitsforschung im Raum Augsburg</italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
We conducted an association study in 386 patients with PCOS (defined by the Rotterdam-criteria) using single nucleotide polymorphisms (SNPs) in or in proximity to the fat mass and obesity associated gene (FTO), insulin-induced gene-2 (INSIG2), transcription factor 7-like 2 gene (TCF7L2) and melanocortin 4 receptor gene (MC4R). To compare the effect of FTO obesity risk alleles on BMI in patients with PCOS to unselected females of the same age range we genotyped 1,971 females from the population-based KORA-S4 study (Kooperative Gesundheitsforschung im Raum Augsburg, Survey 4).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2 </italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
The FTO risk allele was associated with IR traits and measures of increased body weight. In addition, the TCF7L2 SNP was associated with body weight traits. For the SNPs in the vicinity of INSIG2 and MC4R and for the other examined phenotypes there was no evidence for an association. In PCOS the observed per risk allele effect of FTO intron 1 SNP rs9939609 on BMI was +1.56 kg/m2, whereas it was +0.46 kg/m2 in females of the same age range from the general population as shown previously.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
The stronger effect on body weight of the FTO SNP in PCOS might well have implications for the etiology of the disease.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 86 91 <span type="species:ncbi:9606">women</span>
###xml 95 100 <span type="species:ncbi:9606">child</span>
The polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting about 6% of women of child-bearing age [1]. It is classically characterised by chronic anovulation, hyperandrogenism and polycystic ovarian morphology on ultrasonography [2]. In addition, a close relationship exists between obesity, insulin resistance (IR) and PCOS [3,4]. Despite a growing body of evidence demonstrating a substantial heritability of PCOS and the intrinsic impact of IR on the development of PCOS, its etiology and underlying pathophysiology still remains elusive.
###end p 10
###begin p 11
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GWAS</italic>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 940 942 940 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1129 1130 1129 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1228 1230 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1364 1368 1364 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1447 1449 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1531 1535 1531 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1656 1660 1656 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1756 1758 1756 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1904 1910 1904 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2</italic>
###xml 1984 1986 1984 1986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 2125 2127 2125 2127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 2128 2130 2128 2130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 2302 2304 2302 2304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 2441 2443 2441 2443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 2552 2558 2552 2558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 2654 2656 2654 2656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 2730 2732 2730 2732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 2733 2735 2733 2735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 2813 2815 2813 2815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2986 2988 2986 2988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 3029 3036 3029 3036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 3068 3070 3068 3070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 3071 3073 3071 3073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 3074 3076 3074 3076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 3121 3123 3121 3123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 3124 3126 3124 3126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 3127 3129 3127 3129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 3198 3202 3198 3202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 3209 3211 3209 3211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 3287 3294 3287 3294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 3324 3326 3324 3326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 3479 3483 3479 3483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R</italic>
###xml 3486 3488 3486 3488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 3489 3491 3489 3491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 3554 3559 3554 3559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 3610 3612 3610 3612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 3699 3703 3699 3703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R</italic>
###xml 3922 3924 3922 3924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 668 673 <span type="species:ncbi:9606">human</span>
###xml 1736 1744 <span type="species:ncbi:9606">patients</span>
###xml 2398 2406 <span type="species:ncbi:9606">children</span>
###xml 3140 3148 <span type="species:ncbi:9606">patients</span>
To date, multiple genetic studies in PCOS have been performed examining genes coding for enzymes of steroid biosynthesis like CYP11, CYP17, CYP19, androgen receptor, insulin, insulin receptor and enzymes in the post-receptor signal cascade of insulin. However, a variant contributing substantially to the development of the PCOS phenotype was not detected [5-8]. Genome-wide association studies (GWAS) offer a new approach to gene discovery unbiased with regard to the presumed function of causal variants. Up to one million single nucleotide polymorphisms (SNP) that are distributed evenly across the whole genome are commonly used for this approach. In the field of human body weight regulation these studies already had a major impact on the identification of relevant polygenes. For instance, common variants in the fat mass and obesity associated gene (FTO) predispose to an elevated body mass index (BMI) with an increase of 0.36 kg/m2 BMI units per risk allele. Homozygous risk allele carriers weighed about three kilograms more and had 1.67-fold higher odds for obesity compared to adults not inheriting the risk allele [9]. This robust association was also detectable in the first GWAS for early onset extreme obesity [10]. With regard to insulin sensitivity, a recent British study in healthy adults indicated an association between polymorphisms of the FTO gene and a decrease in insulin sensitivity, which was presumably BMI mediated [11]. Barber et al. additionally demonstrated an association between PCOS status and FTO obesity risk SNPs in a case-control study [12]. Using a similar approach, Attaoua et al. discussed the potential role of FTO variants for the glucose intolerance component of the metabolic syndrome in patients with PCOS [13]. Association with increased risk of obesity has also been demonstrated for SNP rs7566605 located ~10 kb upstream of the insulin-induced gene-2 (INSIG2), which was detected in the first population-based GWAS for body weight [14]. Results concerning the influence of this SNP on obesity risk are conflicting, as not all studies detected the association with obesity [15-18]. However, in a meta-analysis of case-control and family-based approaches comprising about 17,000 individuals a marginal effect of rs7566605 on obesity was still present [19]. Recently, Reinehr et al. showed a lower success rate of a lifestyle intervention for obese children homozygous for the risk allele C [20]. A solidly validated gene for type two diabetes mellitus (T2DM) is the transcription factor 7-like 2 gene (TCF7L2). Identified via a conventional genome wide linkage scan for T2DM and subsequent fine mapping [21], it had convincingly been confirmed in numerous studies including GWAS [22-24]. The gene codes for a stimulating regulator of proglucagon gene expression [25]. The proglucagon gene is post-translationally processed to produce GLP-1, a stimulator of insulin secretion and biosynthesis and it is an inhibitor of glucagon release [26]. GWAS reported association of a SNP in TCF7L2 with T2DM and IR in Caucasians [21,27,28] but a negative association to body weight [21,28-30]. In PCOS patients, using a sample size and design similar to their FTO study [12], a case-control comparison did not provide evidence for an association of TCF7L2 variants with disease status [31]. A further (negative) correlation to weight status was robustly found for a non-synonymous polymorphism Val103Ile in the melanocortin-4 receptor gene (MC4R) [32-34]. Interestingly, another genetic locus in the vicinity of the MC4R was recently also detected by a large-scaled GWAS [35]. The respective SNP was associated with obesity; it is located 188 downstream of the MC4R; its effect is presumably exerted by an influence on the expression of the gene. Additionally, another SNP near the previously described one, was shown to be associated with waist circumference and insulin resistance [36].
###end p 11
###begin p 12
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 430 436 430 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2</italic>
###xml 438 445 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 553 561 <span type="species:ncbi:9606">patients</span>
Given the high prevalence of obesity in PCOS and the compelling evidence for a substantial genetic background of both PCOS and obesity, known obesity susceptibility genes emerge as eligible candidates that might also be involved in the development of PCOS. Therefore we examined the influence of the described genetic variants on obesity and other endophenotypes in patients with PCOS. We considered polymorphisms in or near FTO, INSIG2, TCF7L2 and MC4R that are all well supported by large data collections of GWAS or meta-analyses for our analyses in patients with PCOS.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Recruitment
###end title 14
###begin p 15
The study was approved by the Ethics Committees of the University of Essen and Munich. All subjects gave written informed consent. The study was carried out according to the Declaration of Helsinki.
###end p 15
###begin p 16
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 244 252 <span type="species:ncbi:9606">patients</span>
Consecutive, currently untreated patients with PCOS (n = 386) were recruited between 2/2001 and 1/2007 at the outpatient clinic of the Department of Endocrinology and Division of Laboratory Research, University of Duisburg-Essen, Germany. Some patients were also attracted by the PCOS homepage of the clinic . PCOS was defined according to the 2003 Rotterdam criteria, so diagnosis of PCOS was established, if two of the three criteria chronic anovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries (PCO) were fulfilled and other pituitary, adrenal or ovarian diseases could be excluded [2].
###end p 16
###begin title 17
###xml 29 37 <span type="species:ncbi:9606">Patients</span>
Clinical Characterization of Patients
###end title 17
###begin p 18
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 748 750 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
###xml 552 560 <span type="species:ncbi:9606">patients</span>
Participants were carefully characterized with regard to medical history, clinical and socio-demographic variables using questionnaires, interview, and physical examinations, as previously described in detail [37]. Free androgen index (FAI) was calculated as total testosterone [nmol/l] x 100/SHBG [nmol/l]. Bioavailable testosterone concentration was calculated based on measured testosterone, SHBG and albumin levels [38]. Variables of IR and beta-cell function were evaluated using a 3-h oral glucose tolerance test. After an overnight fast of 12 h patients ingested 75 g glucose and had their glucose and insulin levels determined at baseline and at 30, 60, 90, 120 and 180 min. IR was defined by the homeostasis model assessment (HOMA) model [39] and hyperinsulinemia by calculating the area under the curve of insulin response (AUCI).
###end p 18
###begin title 19
Females from the population-based sample (KORA-S4)
###end title 19
###begin p 20
###xml 6 55 6 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kooperative Gesundheitsforschung im Raum Augsburg</italic>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 474 475 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
KORA (Kooperative Gesundheitsforschung im Raum Augsburg, Survey 4; 'Cooperative Health Research in the Region of Augsburg') is an epidemiological study group including 4,261 German adults representative of the population within the age range of 25-74 years in the city and region of Augsburg (Bavaria, Germany); probands were recruited between 1999-2001 [40]. FTO (rs9939609) genotypes as well as phenotype data were available for 1,971 females (mean BMI 26.96 +/- 5.28 kg/m2, mean age 48.85 +/- 13.69 years).
###end p 20
###begin title 21
Biochemical Analyses
###end title 21
###begin p 22
###xml 922 927 <span type="species:ncbi:9606">women</span>
Automated chemiluminescence immunoassay systems were used for the determination of LH, FSH, TSH, testosterone, estradiol, cortisol, free thyroxine, prolactin, blood glucose (ADVIA Centaur, Siemens, Germany), ACTH, dehydroepiandrosterone sulfate, androstenedione, sex hormone-binding globulin, insulin and insulin-like growth factor (IMMULITE 2000, Siemens, Germany). Measurement of blood glucose was performed by photometric determination (ADVIA 2400, Siemens, Germany). Intraassay variation was < 5% and interassay variation was < 8% for all measured variables. 17-hydroxyprogesterone was measured by the BIOSOURCE 17-alpha-OH-RIA-CT kit (Biosource International, California, USA) (analytical sensitivity 0.02 ng/ml) provided by IBL Hamburg (IBL, Gesellschaft fur Immunchemie und Immunbiologie, Hamburg, Germany). The intra- and interassay coefficients of variation were 5.6 and 7.2% respectively. Except for amenorrhoic women, all laboratory variables were determined in the early follicular phase of the menstrual cycle.
###end p 22
###begin title 23
Genotyping
###end title 23
###begin p 24
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 455 459 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 520 524 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 612 619 608 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 690 695 <span type="species:ncbi:42554">tetra</span>
Genomic DNA was isolated from EDTA-anticoagulated blood using standard procedures. Genotyping of FTO SNP rs9939609 was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis of allele-dependent primer extension products as described elsewhere [41]. For MC4R Val103Ile (rs2229616), DNA samples were genotyped as described previously. MC4R SNPs rs17782313 and rs12970134 were genotyped using TaqMan(R) assays (Applied Biosystems, Foster City, CA, USA). All TaqMan(R) probes and primers were purchased from Applied Biosystems (assays on demand; ). For the TCF7L2 rs79031746, genotyping was performed by allele-specific PCR reactions (tetra-ARMS PCR; primers were as follows: (forward inner primer (C allele): 5'-TAGAGAGCTAAGCACTTTTTAGAGAC-3'; reverse inner primer (T allele): 5'-CTCATACGGCAATTAAATTATAGAA-3'; forward outer primer: 5'-AATTTTTTCACATGTGAAGACATAC-3'; reverse outer primer: 5'-AAGAGATGAAATGTAGCAGTGAAG-3'. The C allele is detected by a 202 bp amplicon and the T allele by a 272 bp amplicon. The product size of two outer primers is 424 bp.
###end p 24
###begin p 25
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2 </italic>
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsp</italic>
Genotyping of INSIG2 SNP rs7566605 was carried out by PCR-RFLP with Bsp143I (digests the C-allele; primers: 5'-TGAAGTTGATCTAATGTTCTCTCTCC-3' and 5'-AAACCAAGGGAATCGAGAGC-3'). PCR products were run on ethidium bromide-stained 2.5% agarose gels. Positive controls for the variant alleles and a negative control (water) were run on each gel. To validate the genotypes, allele determinations were rated independently by at least two experienced individuals. Discrepancies were resolved unambiguously either by reaching consensus or by retyping. Missings were retyped.
###end p 25
###begin title 26
Statistical Analyses
###end title 26
###begin p 27
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 972 976 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 980 987 980 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 871 879 <span type="species:ncbi:9606">patients</span>
All genotype distributions were tested for deviations from Hardy Weinberg equilibrium (HWE) using the PLINK software (Version 1.06 [42]) and no evidence for such deviations was detected (all p >> 0.4). All endophenotypes were analysed by either linear or logistic regression analyses using age in years as a covariate. Each SNP was analyzed under an (log-) additive genetic model, except for MC4R (rs2229616), where a dominant mode of inheritance was assumed. Nominal two-sided p-values, genetic effect sizes estimates and 95% confidence intervals (CI) for the estimates were derived. To address, the problem of testing multiple hypotheses, we also derived multiplicity-adjusted p-values for our strongest association signals (see Table three) using a method of described in [43]. As secondary analyses, robust linear regressions were used for the comparison of the PCOS patients with the population-based females and for an exploration of joint or interaction effects of FTO and TCF7L2 SNPs; model assumptions were checked graphically.
###end p 27
###begin p 28
###xml 580 581 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 582 584 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 865 866 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 1002 1010 <span type="species:ncbi:9606">patients</span>
Power calculations were done with the software QUANTO (Version 1.2.3, ). 386 PCOS patients were estimated to yield a power > 0.80 to detect a standardized additive genetic effect size of 0.5 (alpha = 0.05; two-sided) assuming a minor allele frequency (MAF) of 5% and a standard normally distributed phenotype. For larger MAFs like 46.2%, smaller effect sizes of 0.2 will be detectable with a similar power. For comparison, standardized effect sizes like 0.1 have for example been reported for markers in FTO or TCF7L2 in unselected or control individuals for quantitative traits [9,44]. A standardized effect size of e.g. 0.1 in the additive genetic model implies that the distributions for the three genotypes are shifted by 1/10 of as standard deviation for the respective quantitative trait. Thus, except for rs2229616 with its low allele frequency (1.6%, Table 1), the study was well powered to detect strong to moderate genetic effects which might be present in our highly selected sample of PCOS patients.
###end p 28
###begin p 29
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Characteristics of the investigated samples of the patients with PCOS (means and standard deviations or percent).
###end p 29
###begin p 30
BMI = body mass index; F/G = hirsutism-score by Ferriman/Gallwey; FAI = free androgen index; PCO = polycystic ovary; HA = hyperandrogenism; OA = oligo-/amenorrhea; HOMA-IR = homeostasis model assessment for insulin resistance; AUCI = area under the curve of insulin response; MAF = minor allele frequency
###end p 30
###begin title 31
Results
###end title 31
###begin p 32
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
The clinical and phenotypical characteristics of the investigated patients with PCOS as well as the estimated minor allele frequencies (MAFs) are given in Table 1. Table 1 also includes subgroup distributions according to the Rotterdam criteria (hyperandrogenism (HA), oligo-anovulation (OA) and polycystic ovaries (PCO)) as metabolic differences between theses subgroups have been described [45-48].
###end p 32
###begin p 33
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2 </italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 428 430 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 645 652 645 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 736 738 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 811 812 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 903 907 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 933 935 933 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 972 979 972 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 1011 1012 1011 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1025 1029 1025 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1110 1111 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 1503 1518 1503 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2, TCF7L2 </italic>
###xml 1522 1527 1522 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 1587 1588 1587 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Exploration of associations between genotypes and metabolic/obesity related variables in patients with PCOS revealed some evidence for an association of variants in FTO and TCF7L2, whereas no indication of association was observable for SNPs in INSIG2 and MC4R (see Table 2). We estimated that each risk allele of the polymorphism rs9939609 of FTO increased the body weight by ~4.6 kg, whereas the BMI was increased by ~1.6 kg/m2 and the waist circumference increased by ~3.5 cm. Of note, the effect size of rs9939609 on BMI in PCOS was larger than in unselected females from the general population in the same age range (see Figure 1). For the TCF7L2 polymorphism rs7903146 the per risk allele effect was ~4.2 kg body weight, ~1.4 kg/m2 BMI and ~3.4 cm waist circumference, respectively (for details see Table 2). There was no evidence for a potentially strong interaction or a correlation between the FTO (adjusted effect 1.35 kg/m2 in robust linear regression) and the TCF7L2 locus (adjusted effect 1.45 kg/m2). Moreover, FTO variant rs9939609 was associated with variables of insulin resistance (see Table 3). As an example, the estimated per risk allele effect was 3.25 mU/l for fasting insulin, which changed to 1.88 mU/l (95%CI 0.22 mU/l; 3.54 mU/l, p-value = 0.03), if BMI was added as a covariate to the regression model. Thus, even after correcting for BMI, a genetic effect of rs9939609 on fasting insulin levels was observed. By contrast, there was no evidence for an association of SNPs in INSIG2, TCF7L2 and MC4R with variables of insulin resistance (for details see Table 3).
###end p 33
###begin p 34
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
Association analysis for the relationship between validated SNPs in the explored candidate genes and quantitative metabolic/obesity related variables in PCOS with genetic effect sizes estimates derived for an additive genetic (MC4R rs2229616 dominant genetic model) for the minor allele (see also Table 1).
###end p 34
###begin p 35
SNP = single nucleotide polymorphism; BMI = body mass index
###end p 35
###begin p 36
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
Association analysis for the relationship between validated SNPs in the explored candidate genes and quantitative variables of insulin resistance in PCOS with genetic effect sizes estimates derived for an additive genetic model (MC4R rs2229616 dominant genetic model) for the minor allele (see also Table 1).
###end p 36
###begin p 37
SNP = single nucleotide polymorphism; HOMA-IR = homeostasis model assessment for insulin resistance; AUCI = area under the curve of insulin response
###end p 37
###begin p 38
*both associations would have been "significant" at the alpha = 0.10 level if correction for multiple testing would have been applied resulting in adjusted p-values of 0.062 for rs9939609 and fasting insulin and 0.099 for rs9939609 and HOMA-IR
###end p 38
###begin p 39
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Relationship between the <italic>FTO </italic>SNP rs9939609, BMI and age in females for the general population and in patients with PCOS</bold>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Relationship between the FTO SNP rs9939609, BMI and age in females for the general population and in patients with PCOS. Each dot represents one observation; the lines are derived from a robust linear regression on the complete data set of females with BMI as outcome and age (linear), group, genotype in the logadditive model and the interaction group x genotype as predictors.
###end p 39
###begin p 40
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
Finally, we investigated the relationship between the variants and PCOS specific characteristics (for details see Tables 4 and 5). There was no association to chronic anovulation, hirsutism, acne, alopecia or androgen levels for any of the variants. Interestingly, we observed that the obesity risk allele A of the FTO variant rs9939609 was less frequently observed in patients with polycystic ovarian morphology (PCO) compared to PCOS patients without PCO (OR = 0.57, 95%, CI 0.36;0.88, p-value = 0.01) and even after correction for BMI this relationship was still present (OR = 0.60, 95%CI 0.37;0.93, p-value = 0.02).
###end p 40
###begin p 41
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
Association analysis for the relationship between validated SNPs in the explored candidate genes and PCOS symptoms (present/absent) with genetic effect sizes estimates derived for an log-additive genetic model (MC4R rs2229616 dominant genetic model) for the minor allele (see also Table 1).
###end p 41
###begin p 42
SNP = single nucleotide polymorphism; F/G = hirsutism-score by Ferriman/Gallwey
###end p 42
###begin p 43
Note that the hirsutism-score was also evaluated quantitatively similar to the other quantitative measures (in italics).
###end p 43
###begin p 44
###xml 114 145 114 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">variables of hyperandrogenemia </bold>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
Association analysis for the relationship between validated SNPs in the explored candidate genes and quantitative variables of hyperandrogenemia in PCOS with genetic effect sizes estimates derived for a log-additive genetic model (MC4R rs2229616 dominant genetic model) for the minor allele (see also Table 1).
###end p 44
###begin p 45
SNP = single nucleotide polymorphism; FAI = free androgen index
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 198 200 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 378 380 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 396 397 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 614 616 614 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 632 633 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 806 808 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 824 825 824 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 835 836 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 875 877 875 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 893 894 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 904 905 904 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1018 1022 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1298 1302 1298 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1508 1512 1508 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1561 1563 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1578 1582 1578 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 1858 1862 1858 1862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 2020 2024 2020 2024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 2093 2095 2093 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 2240 2244 2240 2244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 2343 2347 2343 2347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 2572 2576 2572 2576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
###xml 1083 1091 <span type="species:ncbi:9606">patients</span>
###xml 1537 1545 <span type="species:ncbi:9606">patients</span>
The influence of FTO intron 1 variation on body weight related phenotypes in patients with PCOS is underscored. In population-based GWAS the estimated per risk allele effect ranged between 0.36 kg/m2 [9] and 0.66 kg/m2 [49] for statistical models with a slightly different set of covariates. In our PCOS sample, we estimated an average effect of the FTO risk allele of 1.56 kg/m2 (95%CI 0.34 kg/m2; 2.78 kg/m2) including age as a quantitative covariate. Thus, the impact of the FTO variants on BMI is larger in PCOS patients than in the general population with an average effect of the FTO risk allele of 0.46 kg/m2 (95%CI 0.17 kg/m2; 0.75 kg/m2) as shown in Figure 1. Of note, our finding is surprisingly similar to those of other studies [12,50]. Barber et al. report a per risk allele effect of 1.1 kg/m2 (95%CI -0.9 kg/m2; 3.2 kg/m2) in their PCOS cases and only 0.5 kg/m2 (95%CI -0.1 kg/m2; 1.3 kg/m2) in their controls [12]. Moreover, this study is, to our knowledge, the first to describe a correlation between FTO rs9939609 and insulin resistance or hyperinsulinemia in PCOS patients reflected in fasting insulin, HOMA-IR as well as in AUCI levels After strictly controlling for the multiple statistical tests performed here (multiple phenotypes and multiple SNPs) the adjusted p-value for FTO rs9939609 and fasting insulin was 0.062 and the related effect, though weaker, was still present even after statistically correcting for BMI. Other study groups could not demonstrate an association between FTO and IR in obese and T2DM patients, respectively [51,52]. In PCOS, FTO variation seems to be a key marker for IR, either directly i.e. to some degree independent of BMI/obesity or secondary due to its impact on body weight which in turn has an impact on glucose intolerance and diabetes. Barber et al. at first demonstrated an association between FTO and PCOS status and hypothesized a mediation of this association by adiposity. However, in this British sample, no IR data were available. In a French sample FTO was associated with both glucose intolerance and metabolic syndrome [13] without finding an association to IR. The greater effect on BMI and association to IR in PCOS possibly reflects a pathogenetic function of the FTO gene in the development of PCOS. This study and the data from Barber et al. demonstrated, that the FTO gene does not influence any of the PCOS defining traits neither directly nor indirectly via an effect on obesity or IR. In this German cohort, it is even less frequently associated with PCO. In case of a pathogenetic role of FTO in PCOS, it seems to be limited to determine only the metabolic phenotype.
###end p 47
###begin p 48
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 401 408 401 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 683 690 683 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 854 860 854 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 911 918 911 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 978 985 978 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1214 1221 1214 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
As second strongest signal, we found association between the T2DM susceptibility gene TCF7L2 risk allele and obesity related traits in patients with PCOS. The TCF7L2 obesity association was stochastically independent of the FTO association if assessed in a multiple regression analysis. While some did not find an influence on body weight [29,30,53-56], others have reported analogous associations of TCF7L2 and obesity related traits [28,43,57]. Despite possible effects related to differences in ascertainment schemes, multiple explanations for this conflicting findings are possible [57]. One possible explanation by Cauchi and collegues [43] is that the risk for T2DM related to TCF7L2 seems to be modulated by the obesity status of an individual with stronger effects in the obese. It is possible that our study picked-up this BMI-related effect of TCF7L2. As we observed no evidence for an association of TCF7L2 with IR or other PCOS specific symptoms, common variants of TCF7L2 most likely influence T2DM susceptibility through impairment of insulin secretion rather than IR [56,58]. Interestingly, this observation is consistent with the PCOS data of Barber et al. [12] who failed to detect association of TCF7L2 variation but who do not report on the genotype dependent BMI-distribution.
###end p 48
###begin p 49
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2 </italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
Finally, our data on rs7566605 located ~10 kb upstream of INSIG2 and on markers in proximity to MC4R provided no evidence for an involvement in the development of PCOS or related endophenotypes.
###end p 49
###begin title 50
Conclusion
###end title 50
###begin p 51
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2</italic>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2 </italic>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
In summary, we explored (mainly) GWAS-derived candidate gene markers for obesity and T2DM in patients with PCOS. We show that the impact of INSIG2, TCF7L2 and MC4R SNPs on multiple endophenotypes might either be rather weak or not present at all. For genetic variation in intron 1 of FTO we provide evidence for associations to metabolic aspects of PCOS with some emphasis on IR. Interestingly, the estimated effect on obesity seems to be larger than the effect derived from population-based samples. This stronger effect might well have implications for the etiology of the disease requiring focussed functional studies.
###end p 51
###begin title 52
Competing interests
###end title 52
###begin p 53
The authors declare that they have no competing interests.
###end p 53
###begin title 54
Authors' contributions
###end title 54
###begin p 55
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 521 528 521 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSIG2 </italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R </italic>
###xml 720 724 720 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO </italic>
ST contributed substantially to conception and design of the study, acquisition of data, analysis and interpretation of data and drafted the manuscript. AS contributed substantially to conception and design of the study, analysis of data, performed the statistical analysis and drafted the manuscript. OEJ, SH, HL, TD, RK and KM contributed to acquisition of data and revised the manuscript critically for important intellectual content. SS and CIGV carried out the molecular genetic studies for polymorphisms of TCF7L2, INSIG2 and MC4R and revised the manuscript critically for important intellectual content. HG and TI contributed to acquisition of data, carried out the molecular genetic studies for polymorphisms of FTO and revised the manuscript critically for important intellectual content. JH and AH contributed substantially to conception and design of the study, analysis and interpretation of data and were involved in drafting the manuscript and haves given final approval of the version to be published. All authors read and approved the final manuscript.
###end p 55
###begin title 56
Pre-publication history
###end title 56
###begin p 57
The pre-publication history for this paper can be accessed here:
###end p 57
###begin p 58

###end p 58
###begin title 59
Acknowledgements
###end title 59
###begin p 60
We thank the probands for their participation.
###end p 60
###begin p 61
###xml 43 88 43 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bundesministerium fuer Bildung und Forschung </italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLUS </italic>
###xml 93 98 93 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>PLUS </italic></sup>
###xml 113 145 113 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Deutsche Forschungsgemeinschaft </italic>
This work was supported by grants from the Bundesministerium fuer Bildung und Forschung (NGFNPLUS 01GS0820), the Deutsche Forschungsgemeinschaft (HE 1446/4-2, HE 1446/9-1) and the European Union (FP6 LSHMCT-2003-503041).
###end p 61
###begin article-title 62
The prevalence and features of the polycystic ovary syndrome in an unselected population
###end article-title 62
###begin article-title 63
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
###end article-title 63
###begin article-title 64
###xml 80 85 <span type="species:ncbi:9606">women</span>
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
###end article-title 64
###begin article-title 65
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
###end article-title 65
###begin article-title 66
###xml 51 56 <span type="species:ncbi:9606">women</span>
Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
###end article-title 66
###begin article-title 67
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
###end article-title 67
###begin article-title 68
Molecular progress in infertility: polycystic ovary syndrome
###end article-title 68
###begin article-title 69
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity
###end article-title 69
###begin article-title 70
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity
###end article-title 70
###begin article-title 71
Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants
###end article-title 71
###begin article-title 72
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function
###end article-title 72
###begin article-title 73
Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome
###end article-title 73
###begin article-title 74
###xml 45 50 <span type="species:ncbi:9606">women</span>
FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome
###end article-title 74
###begin article-title 75
A common genetic variant is associated with adult and childhood obesity
###end article-title 75
###begin article-title 76
The common genetic variant upstream of INSIG2 gene is not associated with obesity in Indian population
###end article-title 76
###begin article-title 77
Comment on "A common genetic variant is associated with adult and childhood obesity"
###end article-title 77
###begin article-title 78
Comment on "A common genetic variant is associated with adult and childhood obesity"
###end article-title 78
###begin article-title 79
Comment on "A common genetic variant is associated with adult and childhood obesity"
###end article-title 79
###begin article-title 80
The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts
###end article-title 80
###begin article-title 81
###xml 115 123 <span type="species:ncbi:9606">children</span>
Evidence of an influence of a polymorphism near the INSIG2 on weight loss during a lifestyle intervention in obese children and adolescents
###end article-title 81
###begin article-title 82
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
###end article-title 82
###begin article-title 83
Genome-wide association with diabetes-related traits in the Framingham Heart Study
###end article-title 83
###begin article-title 84
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
###end article-title 84
###begin article-title 85
Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans
###end article-title 85
###begin article-title 86
TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta
###end article-title 86
###begin article-title 87
Therapeutic strategies based on glucagon-like peptide 1
###end article-title 87
###begin article-title 88
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 88
###begin article-title 89
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
###end article-title 89
###begin article-title 90
Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals
###end article-title 90
###begin article-title 91
###xml 82 87 <span type="species:ncbi:9606">human</span>
Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes
###end article-title 91
###begin article-title 92
Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS
###end article-title 92
###begin article-title 93
Melanocortin-4 receptor gene variant I103 is negatively associated with obesity
###end article-title 93
###begin article-title 94
###xml 69 81 <span type="species:ncbi:9606">participants</span>
Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys
###end article-title 94
###begin article-title 95
The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals
###end article-title 95
###begin article-title 96
Common variants near MC4R are associated with fat mass, weight and risk of obesity
###end article-title 96
###begin article-title 97
Common genetic variation near MC4R is associated with waist circumference and insulin resistance
###end article-title 97
###begin article-title 98
Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance
###end article-title 98
###begin article-title 99
A critical evaluation of simple methods for the estimation of free testosterone in serum
###end article-title 99
###begin article-title 100
Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes
###end article-title 100
###begin article-title 101
KORA--a research platform for population based health research
###end article-title 101
###begin article-title 102
Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study
###end article-title 102
###begin article-title 103
PLINK: a tool set for whole-genome association and population-based linkage analyses
###end article-title 103
###begin article-title 104
The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies
###end article-title 104
###begin article-title 105
TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study
###end article-title 105
###begin article-title 106
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype
###end article-title 106
###begin article-title 107
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
###end article-title 107
###begin article-title 108
###xml 29 34 <span type="species:ncbi:9606">women</span>
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome
###end article-title 108
###begin article-title 109
Oligoanovulation with polycystic ovaries but not overt hyperandrogenism
###end article-title 109
###begin article-title 110
Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits
###end article-title 110
###begin article-title 111
###xml 66 71 <span type="species:ncbi:9606">women</span>
The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes
###end article-title 111
###begin article-title 112
Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population
###end article-title 112
###begin article-title 113
The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis
###end article-title 113
###begin article-title 114
Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys
###end article-title 114
###begin article-title 115
Effects of the diabetes linked TCF7L2 polymorphism in a representative older population
###end article-title 115
###begin article-title 116
Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population
###end article-title 116
###begin article-title 117
TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population
###end article-title 117
###begin article-title 118
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program
###end article-title 118
###begin article-title 119
Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles
###end article-title 119

